Search results for: 'Conversation AI in Healthcare'

During the forecast period (2023 to 2029), the North American (NA) customer experience (CX) outsourcing services market is expected to expand, mainly due to 2 factors: 1) the growing recognition of CX as a potent tool for competitive advantage and 2) the increasing motivation for businesses to outsource their CX activities. This market is poised...

21 Sep 2023  |  North America  |  Market Research

Growth Opportunities in the Global Digital Therapeutics Market

Preventive Care and Market Access Strategies Spur New Growth Opportunities

Infographics

×

This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global digital therapeutics (DTx) market and highlights key growth opportunities for global DTx market participants. Patients with long-term chronic conditions increasingly seek safe, evidence-based digital treatments to reduce their medication dosages,...

22 Jan 2025  |  Global  |  Technology Research

Medical Spectral Imaging: Assessment of Technology Trends and Growth Opportunities

Artificial intelligence, system miniaturization, and sensor innovation to drive transformational growth

Infographics

×

Medical spectral imaging is an advanced imaging technique that integrates spectroscopy with photography to capture the reflectance spectrum of tissues, facilitating a range of applications from tissue analysis to surgical guidance. This non-invasive approach provides real-time data and detailed insights, enhancing decision-making accuracy in diseas...

29 Jan 2021  |  Global  |  Market Research

Packaging and ICT Industry Convergence Propels Advancement of the Global Smart Label Materials Market

Increasing Requirements for Digital Tracing and Tracking in the Retail, Healthcare, and Food & Beverage Value Chains Fuel Growth Strategies

Infographics

×

Key Issues Addressed

Frost & Sullivans study of the global smart label materials market analyzes the growth drivers, challenges, and trends that affect participants in this space. The study period is 2017 to 2027 using a base year of 2020 and a forecast period of 2021 to 2027. The global market is segmented into the following regions: Americas, Europe, Middle East, Afr...

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.These disruptions continue to drive ...

The pharmaceutical (pharma) industry is undergoing significant regulatory changes resulting from the European Green Deal and the Paris Agreement. These changes require pharma companies to adopt more environmentally sustainable practices. With the increasing demand for drugs globally, pharma R&D and manufacturing infrastructure has grown, leading to...

As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs...

Artificial intelligence is a core transformation lever across industrial design and engineering. Product complexity, shorter development cycles, and the need for mass customization are overwhelming traditional workflows, making AI-enabled design, engineering, simulation, and decision-making support key for competitiveness. AI-based tools, such as g...